RE: 🔥 RED to BLUE13 Feb 2025 14:38
Just to clarify timelines etc
The European Medicines Agency (EMA) typically reaches a final decision on an orphan drug designation within 90 days from the submission date. This means that Nuformix should expect a decision by April 12, 2025, assuming the submission was validated promptly.
This could of course happen earlier as is the case with numerous other applications - however 2 months is not a long time, and i believe that the SP will increase sharply nearer the time - that is the norm - with this one it is enhanced by the continuance of NXP004 which will see the SP go North again - a double wammy !!!
Where the SP lands after NXP002 is exciting - knowing that there will be the more excitement to come - those who bought in at Januarys level are in for a multi multi bag - IMHO.